Saxagliptin co-therapy in C-peptide negative Type 1 diabetes does not improve counter-regulatory responses to hypoglycaemia

P. S. George, R. J. McCrimmon (Lead / Corresponding author)

    Research output: Contribution to journal › Article › peer-review

    8 Citations (Scopus)
    464 Downloads (Pure)

    Fingerprint

    Dive into the research topics of 'Saxagliptin co-therapy in C-peptide negative Type 1 diabetes does not improve counter-regulatory responses to hypoglycaemia'. Together they form a unique fingerprint.

    Keyphrases

    Medicine and Dentistry

    Pharmacology, Toxicology and Pharmaceutical Science

    Biochemistry, Genetics and Molecular Biology

    Neuroscience